Safety and efficacy of trisectionectomy for hepatocellular carcinoma

ANZ Journal of Surgery

Volumn 81, Issue 12, 2011, Pages 895-899

  Zhou, Yanming ^a,b   Sui, Chengjun ^b   Li, Bin ^a   Kan, Tong ^b   Yang, Jiamei ^b   Wu, Mengchao ^b  

^a THE FIRST AFFILIATED HOSPITAL OF XIAMEN UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Survival; Trisectionectomy

Indexed keywords

ADULT; AGED; ARTICLE; EVALUATION; FEMALE; FOLLOW UP; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TUMOR; MALE; METHODOLOGY; MIDDLE AGED; MORTALITY; POSTOPERATIVE COMPLICATION; RETROSPECTIVE STUDY; SURVIVAL; TREATMENT OUTCOME;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 82955233716     PISSN: 14451433     EISSN: 14452197     Source Type: Journal    
DOI: 10.1111/j.1445-2197.2010.05605.x     Document Type: Article

References (44)

1. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007; 132: 2557-76.
2. Lau WY, Lai EC. Hepatocellular carcinoma: current management and recent advances. Hepatobiliary Pancreat. Dis. Int. 2008; 7: 237-57.
3. Song TJ, Ip EW, Fong Y. Hepatocellular carcinoma: current surgical management. Gastroenterology 2004; 127: S248-60.
4. Starzl TE, Koep LJ, Weil R 3rd, Lilly JR, Putnam CW, Aldrete JA. Right trisegmentectomy for hepatic neoplasms. Surg. Gynecol. Obstet. 1980; 150: 208-14.
5. Starzl TE, Iwatsuki S, Shaw BW Jr, Waterman PM, Van Thiel D, Diliz HS. Left hepatic trisegmentectomy. Surg. Gynecol. Obstet. 1982; 155: 21-7.
6. Hasegawa H, Yamasaki S, Makuuchi M, Shimamura Y, Gunvén P. Poor prognoses following left hepatic trisegmentectomies for cancer. Jpn. J. Clin. Oncol. 1989; 19: 271-5.
7. Rui JA, Wang SB, Chen SG, Zhou L. Right trisectionectomy for primary liver cancer. World J. Gastroenterol. 2003; 9: 706-9.
8. Shimada K, Sano T, Sakamoto Y, Kosuge T. Safety and effectiveness of left hepatic trisegmentectomy for hilar cholangiocarcinoma. World J. Surg. 2005; 29: 723-7.
9. Nishio H, Hidalgo E, Hamady ZZ etal. Left hepatic trisectionectomy for hepatobiliary malignancy: results and an appraisal of its current role. Ann. Surg. 2005; 242: 267-75.
10. Lang H, Sotiropoulos GC, Brokalaki EI etal. Left hepatic trisectionectomy for hepatobiliary malignancies. J. Am. Coll. Surg. 2006; 203: 311-21.
11. Halazun KJ, Al-Mukhtar A, Aldouri A etal. Right hepatic trisectionectomy for hepatobiliary diseases: results and an appraisal of its current role. Ann. Surg. 2007; 246: 1065-74.
12. Llovet JM, Brù C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin. Liver Dis. 1999; 19: 329-38.
13. Liau KH, Ruo L, Shia J etal. Outcome of partial hepatectomy for large (>10cm) hepatocellular carcinoma. Cancer 2005; 104: 1948-55.
14. Edmondson HA, Steiner PE. Primary carcinoma of the liver. A study of 100 cases among 48, 900 necropsies. Cancer 1954; 7: 462-503.
15. Pawlik TM, Poon RT, Abdalla EK etal. Critical appraisal of the clinical and pathologic predictors of survival after resection of large hepatocellular carcinoma. Arch. Surg. 2005; 140: 450-7.
16. Tsai TJ, Chau GY, Lui WY etal. Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma. Surgery 2000; 127: 603-8.
17. Strasberg SM. Nomenclature of hepatic anatomy and resections: a review of the Brisbane 2000 system. J. Hepatobiliary Pancreat. Surg. 2005; 12: 351-5.
18. Suda K, Ohtsuka M, Ambiru S etal. Risk factors of liver dysfunction after extended hepatic resection in biliary tract malignancies. Am. J. Surg. 2009; 197: 752-8.
19. Redaelli CA, Dufour JF, Wagner M etal. Preoperative galactose elimination capacity predicts complications and survival after hepatic resection. Ann. Surg. 2002; 235: 77-85.
20. Fazakas J, Mándli T, Ther G etal. Evaluation of liver function for hepatic resection. Transplant. Proc. 2006; 38: 798-800.
21. Bruix J, Castells A, Bosch J etal. Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology 1996; 111: 1018-22.
22. Bruix J, Sherman M. Management of hepatocellular carcinoma. AASLD practice guideline. Hepatology 2005; 42: 1208-35.
23. Giannini EG, Risso D, Testa R etal. Prevalence and prognostic significance of the presence of esophageal varices in patients with hepatocellular carcinoma. Clin. Gastroenterol. Hepatol. 2006; 4: 1378-84.
24. Capussotti L, Ferrero A, Viganò L, Muratore A, Polastri R, Bouzari H. Portal hypertension: contraindication to liver surgery. World J. Surg. 2006; 30: 992-9.
25. Kawano Y, Sasaki A, Kai S etal. Short- and long-term outcomes after hepatic resection for hepatocellular carcinoma with concomitant esophageal varices in patients with cirrhosis. Ann. Surg. Oncol. 2008; 15: 1670-6.
26. Cucchetti A, Ercolani G, Vivarelli M etal. Is portal hypertension a contraindication to hepatic resection. Ann. Surg. 2009; 250: 922-8.
27. Schindl MJ, Redhead DN, Fearon KC etal. The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection. Gut 2005; 54: 289-96.
28. Shirabe K, Shimada M, Gion T etal. Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume. J. Am. Coll. Surg. 1999; 188: 304-9.
29. Vauthey JN, Chaoui A, Do KA etal. Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. Surgery 2000; 127: 512-19.
30. Liu H, Zhu S. Present status and future perspectives of preoperative portal vein embolization. Am. J. Surg. 2009; 197: 686-90.
31. Wakabayashi H, Ishimura K, Okano K etal. Is preoperative portal vein embolization effective in improving prognosis after major hepatic resection in patients with advanced-stage hepatocellular carcinoma. Cancer 2001; 92: 2384-90.
32. Abdalla EK, Hicks ME, Vauthey JN. Portal vein embolization: rationale, technique and future prospects. Br. J. Surg. 2001; 88: 165-75.
33. Azoulay D, Castaing D, Krissat J etal. Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver. Ann. Surg. 2000; 232: 665-72.
34. Smyrniotis VE, Kostopanagiotou GG, Gamaletsos EL etal. Total versus selective hepatic vascular exclusion in major liver resections. Am. J. Surg. 2002; 183: 173-8.
35. van Gulik TM, de Graaf W, Dinant S, Busch OR, Gouma DJ. Vascular occlusion techniques during liver resection. Dig. Surg. 2007; 24: 274-81.
36. Li AJ, Pan ZY, Zhou WP etal. Comparison of two methods of selective hepatic vascular exclusion for liver resection involving the roots of the hepatic veins. J. Gastrointest. Surg. 2008; 12: 1383-90.
37. Man K, Fan ST, Ng IO, Lo CM, Liu CL, Wong J. Prospective evaluation of Pringle maneuver in hepatectomy for liver tumors by a randomized study. Ann. Surg. 1997; 226: 704-11.
38. Lesurtel M, Selzner M, Petrowsky H, McCormack L, Clavien PA. How should transection of the liver be performed?: a prospective randomized study in 100 consecutive patients: comparing four different transection strategies. Ann. Surg. 2005; 242: 814-22.
39. Pamecha V, Gurusamy KS, Sharma D, Davidson BR. Techniques for liver parenchymal transection: a meta-analysis of randomized controlled trials. HPB (Oxford) 2009; 11: 275-81.
40. Melendez J, Ferri E, Zwillman M etal. Extended hepatic resection: a 6-year retrospective study of risk factors for perioperative mortality. J. Am. Coll. Surg. 2001; 192: 47-53.
41. Wei AC, Tung-Ping Poon R, Fan ST, Wong J. Risk factors for perioperative morbidity and mortality after extended hepatectomy for hepatocellular carcinoma. Br. J. Surg. 2003; 90: 33-41.
42. Yu YQ, Xu DB, Zhou XD, Lu JZ, Tang ZY, Mack P. Experience with liver resection after hepatic arterial chemoembolization for hepatocellular carcinoma. Cancer 1993; 71: 62-5.
43. Wu CC, Ho YZ, Ho WL, Wu TC, Liu TJ, P'eng FK. Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: a reappraisal. Br. J. Surg. 1995; 82: 122-6.
44. Zhou WP, Lai EC, Li AJ etal. A prospective, randomized, controlled trial of preoperative transarterial chemoembolization for resectable large hepatocellular carcinoma. Ann. Surg. 2009; 249: 195-202.